LogicBio Therapeutics (LOGC) Misses Q2 EPS by 50c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Sales, general and administrative: 167.9K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +82.6%
Financial Fact:
Sales, general and administrative: 167.9K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.50).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Rocket Lab launches U.S. Space Force mission in record 16 hours
- Qualcomm (QCOM) PT Raised to $195 at BofA Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
